Lorna Cawkwell

651 total citations
7 papers, 459 citations indexed

About

Lorna Cawkwell is a scholar working on Rheumatology, Hematology and Orthopedics and Sports Medicine. According to data from OpenAlex, Lorna Cawkwell has authored 7 papers receiving a total of 459 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Rheumatology, 5 papers in Hematology and 1 paper in Orthopedics and Sports Medicine. Recurrent topics in Lorna Cawkwell's work include Rheumatoid Arthritis Research and Therapies (7 papers), Spondyloarthritis Studies and Treatments (7 papers) and Autoimmune and Inflammatory Disorders Research (5 papers). Lorna Cawkwell is often cited by papers focused on Rheumatoid Arthritis Research and Therapies (7 papers), Spondyloarthritis Studies and Treatments (7 papers) and Autoimmune and Inflammatory Disorders Research (5 papers). Lorna Cawkwell collaborates with scholars based in United Kingdom and Spain. Lorna Cawkwell's co-authors include Laura C. Coates, Paul Emery, Alexander N. Bennett, E. Hensor, Helen Keen, Nick Barkham, Alexander Fraser, Dennis McGonagle, Alexander Fraser and Philip O’Connor and has published in prestigious journals such as Annals of the Rheumatic Diseases, Lara D. Veeken and Rheumatic Disease Clinics of North America.

In The Last Decade

Lorna Cawkwell

7 papers receiving 446 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lorna Cawkwell United Kingdom 6 447 263 153 63 16 7 459
I. Spiller Germany 7 427 1.0× 279 1.1× 117 0.8× 44 0.7× 18 1.1× 12 470
Mau R Germany 4 333 0.7× 170 0.6× 77 0.5× 70 1.1× 16 1.0× 6 345
Claudia Klink Germany 4 322 0.7× 234 0.9× 87 0.6× 49 0.8× 8 0.5× 6 326
J Brückel United States 6 363 0.8× 175 0.7× 134 0.9× 30 0.5× 58 3.6× 9 393
Elmar Schmitz-Bortz Germany 6 429 1.0× 306 1.2× 115 0.8× 57 0.9× 11 0.7× 10 438
M. Igelmann Germany 6 430 1.0× 307 1.2× 115 0.8× 57 0.9× 11 0.7× 12 440
M. Bohl-Bühler Germany 10 449 1.0× 209 0.8× 156 1.0× 66 1.0× 21 1.3× 24 485
M. van Lunteren Netherlands 15 503 1.1× 290 1.1× 116 0.8× 177 2.8× 18 1.1× 34 518
L. Myasoutova Russia 5 226 0.5× 175 0.7× 60 0.4× 27 0.4× 8 0.5× 14 261
D Halter United States 5 302 0.7× 225 0.9× 160 1.0× 18 0.3× 15 0.9× 9 357

Countries citing papers authored by Lorna Cawkwell

Since Specialization
Citations

This map shows the geographic impact of Lorna Cawkwell's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lorna Cawkwell with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lorna Cawkwell more than expected).

Fields of papers citing papers by Lorna Cawkwell

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lorna Cawkwell. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lorna Cawkwell. The network helps show where Lorna Cawkwell may publish in the future.

Co-authorship network of co-authors of Lorna Cawkwell

This figure shows the co-authorship network connecting the top 25 collaborators of Lorna Cawkwell. A scholar is included among the top collaborators of Lorna Cawkwell based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lorna Cawkwell. Lorna Cawkwell is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

7 of 7 papers shown
1.
Barkham, Nick, Laura C. Coates, Helen Keen, et al.. (2010). Double-blind placebo-controlled trial of etanercept in the prevention of work disability in ankylosing spondylitis. Annals of the Rheumatic Diseases. 69(11). 1926–1928. 56 indexed citations
2.
Barkham, Nick, Helen Keen, Laura C. Coates, et al.. (2009). Clinical and imaging efficacy of infliximab in HLA–B27–Positive patients with magnetic resonance imaging–determined early sacroiliitis. Arthritis & Rheumatism. 60(4). 946–954. 216 indexed citations
3.
Keen, Helen, Laura C. Coates, Patrick J. O’Connor, et al.. (2008). A randomized controlled trial of infliximab shows clinical and MRI efficacy in HLA B27 positive very early ankylosing spondylitis. Clinical and Experimental Rheumatology. 26. 745–745. 11 indexed citations
4.
Coates, Laura C., Lorna Cawkwell, Alexander N. Bennett, et al.. (2008). Real life experience confirms sustained response to long-term biologics and switching in ankylosing spondylitis. Lara D. Veeken. 47(6). 897–900. 64 indexed citations
5.
Sivera, Francisca, Lorna Cawkwell, Helena Marzo‐Ortega, et al.. (2008). MRI and clinical findings in patients with ankylosing spondylitis eligible for anti-tumour necrosis factor therapy after a short course of etoricoxib. Annals of the Rheumatic Diseases. 68(9). 1466–1469. 66 indexed citations
6.
Coates, Laura C., Lorna Cawkwell, Alexander N. Bennett, et al.. (2007). Sustained response to long-term biologics and switching in psoriatic arthritis: results from real life experience. Annals of the Rheumatic Diseases. 67(5). 717–719. 43 indexed citations
7.
Marzo‐Ortega, Helena, Lorna Cawkwell, & Michael J. Green. (2005). Early Oligoarthritis. Rheumatic Disease Clinics of North America. 31(4). 627–639. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026